Education
About Us
Working with TipRanks
Follow Us
Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE
Sti-6129
Light Chain (Al) Amyloidosis
Phase I
Withdrawn
An Open-Label Study of the Safety of an Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients With AL Amyloidosis
Jan 11, 2023
―
Sti-6129
Advanced Solid Tumor
Phase I
Not Yet Recruiting
Study to Access Anti-CD38 Anibody Drug in Patients With Advanced Solid Tumors
Oct 12, 2022
―
Sti-9199
Covid-19
Phase II
Withdrawn
Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and Adolescents
May 10, 2022
―
Sti-1386
Solid Tumor, Cancer, Sarcoma, Hepatic Metastasis, Cancer Of Pancreas
Phase I
Not Yet Recruiting
Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors
Apr 27, 2022
―
Sti-1558
Covid-19
Phase I
Completed
Study to Assess the Safety, Tolerability and Pharmacokinetics of STI-1558 in Healthy Volunteers
Apr 15, 2022
―
Abiraterone, Abivertinib
Prostate Cancer, Prostate Cancer Metastatic
Phase II
Suspended
Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer
Apr 15, 2022
―
Sti-6129
Multiple Myeloma
Phase I/II
Active Not Recruiting
Study to Assess Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma
Mar 15, 2022
―
Covi-Drops
Covid-19
Phase II
Withdrawn
Randomized Study to Evaluate Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With Mild COVID-19 Infection
Oct 07, 2021
―
Resiniferatoxin
Pain, Pain, Intractable, Pain Cancer
Phase II
Suspended
Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer
Sep 17, 2021
―
Sti-3258
Solid Tumor, Adult, Relapsed Solid Neoplasm, Refractory Cancer
Phase I
Withdrawn
Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid Tumors
Aug 20, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sorrento Therapeutics (SRNE) have in its pipeline
SRNE is currently developing the following drugs: Sti-6129, Sti-6129, Sti-9199. These drug candidates are in various stages of clinical development as the company works toward FDA approval.